Overall, there were 28 deaths among 3,570 patients with IMIDs and type 2 diabetes initiating a GLP-1-RA (8.5 per 1,000 person-years) compared to 446 deaths among 7,285 patients initiating a DPP-4i (17.9 per 1,000 person-years), yielding a weighted HR of 0.48 (CI 0.31–0.75) and RD of -9.4 (CI -16.0 to -2.7) per 1,000 person-years for all-cause mortality (Table 2). Here, GLP1R is linked to rheumatoid arthritis.